Envision Healthcare, the large chain of outpatient surgery centers and physician staffing services for hospitals, is on the cusp of bankruptcy and likely will run out of cash by the end of next year.
Moody’s Investors Service on Wednesday downgraded Envision’s debt to its lowest possible junk-level rating, one that indicates the debt is “typically in default, with little prospect for recovery of principal and interest.” Envision’s debt has been distressed since the pandemic started — concerning many lenders and investors — but now financial analysts are warning the health care firm is on borrowed time.
“Envision’s capital structure is unsustainable, the probability of a bankruptcy or major restructuring is high, and recovery rates for much of the company’s debt will be low,” Moody’s analysts said in a release. “Continuing business pressures and increased interest expense will cause Envision’s free cash flow to be significantly negative in 2022 and beyond.”
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect